Psychiatry News and Research RSS Feed - Psychiatry News and Research

Psychiatry is the treatment, study and prevention of mental disorders.
Common antidepressant medications not helpful for people with mood, anxiety disorders

Common antidepressant medications not helpful for people with mood, anxiety disorders

Studies indicate that the majority of people with mood and anxiety disorders who receive the most commonly prescribed class of antidepressant medications, Selective Serotonin Reuptake Inhibitors or SSRI's, are not helped by these medications. SSRIs are designed to increase serotonin, a neurotransmitter in the brain that is key to maintenance of mood. [More]
Study: Family Based Interpersonal Psychotherapy effective in treating preadolescents with depression

Study: Family Based Interpersonal Psychotherapy effective in treating preadolescents with depression

A recent study published in the March 2015 issue of the Journal of the American Academy of Child and Adolescent Psychiatry finds that Family Based Interpersonal Psychotherapy (FB-IPT) is more effective in treating preadolescent children with depression compared to child-centered therapy (CCT). [More]
NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

NeuroPerspective features comprehensive reviews of schizophrenia, spinal cord injury

NI Research has released the March/April issue of NeuroPerspective, which features comprehensive reviews of two major areas: Schizophrenia and Spinal cord injury. [More]
Study shows strong link between subthreshold manic episodes and bipolar disorder in children

Study shows strong link between subthreshold manic episodes and bipolar disorder in children

New research published today in the American Journal of Psychiatry indicates a strong link between subthreshold manic episodes and likelihood of developing bipolar disorder in children of parents with bipolar disorder. The study's findings could improve clinical assessment and care for these high-risk children by potentially enabling earlier identification, treatment or possible preventive measures. [More]
Global trends in health inequalities among young people related to income inequality

Global trends in health inequalities among young people related to income inequality

Health inequalities in young people have grown alongside socioeconomic disparities between the rich and poor. [More]
Successful cognitive behavioral therapy for childhood anxiety provides long-term benefits

Successful cognitive behavioral therapy for childhood anxiety provides long-term benefits

Penn Medicine researchers found that patients who did not respond to cognitive behavioral therapy (CBT) for anxiety in childhood had more chronic and enduring patterns of suicidal ideation at 7 to 19 years after treatment. [More]
UTHealth study focuses on new cognitive behavioral therapy to treat PTSD, substance use disorders

UTHealth study focuses on new cognitive behavioral therapy to treat PTSD, substance use disorders

A new cognitive behavioral therapy designed to treat both post-traumatic stress disorder (PTSD) and substance use disorders is the focus of research at The University of Texas Health Science Center at Houston Medical School. [More]
New study examines risk factors for use of synthetic marijuana among teens

New study examines risk factors for use of synthetic marijuana among teens

Synthetic cannabinoids ("synthetic marijuana"), with names like Spice, K2, Scooby Doo and hundreds of others, are often sold as a "legal" alternative to marijuana. Often perceived as a safe legal alternative to illicit drug use, synthetic marijuana use was associated with 11,561 reports of poisonings in the United States between January 2009 and April 2012. [More]
Transition completes enrolment of patients in ELND005 Phase 2 study for treatment of AD patients

Transition completes enrolment of patients in ELND005 Phase 2 study for treatment of AD patients

Transition Therapeutics Inc. announced that its wholly owned subsidiary, Transition Therapeutics Ireland Limited completed enrolment of the Phase 2 clinical study evaluating neuropsychiatric drug candidate ELND005 as a treatment for agitation and aggression in patients with mild, moderate and severe Alzheimer's disease ("AD"). [More]
Study explores use of antipsychotic medications among pediatric patients

Study explores use of antipsychotic medications among pediatric patients

More kids nationwide are taking medications designed to treat such mental illnesses as schizophrenia and bipolar disorder, and pediatricians and psychiatrists at the University of Vermont want to know why. [More]

Study could help boost suicide prevention efforts in the U.S.

A study that could help to bolster suicide prevention efforts has examined the prevalence of suicidal ideation and suicide attempts among adults who reported psychotic experiences. [More]
New technology could help researchers advance blood biomarker capabilities for TBI

New technology could help researchers advance blood biomarker capabilities for TBI

New technology being introduced at NYU Langone Medical Center could help researchers advance blood biomarker capabilities that show changes in low concentrations of specific proteins present following a neurological injury. [More]
Study suggests that strong beliefs can treat nicotine addiction

Study suggests that strong beliefs can treat nicotine addiction

Two identical cigarettes led to a discovery by scientists at the Virginia Tech Carilion Research Institute. Study participants inhaled nicotine, yet they showed significantly different brain activity. Why the difference? Some subjects were told their cigarettes were nicotine free. [More]
Pain from social rejection lasts longer for people with untreated depression

Pain from social rejection lasts longer for people with untreated depression

Rejected by a person you like? Just "shake it off" and move on, as music star Taylor Swift says. [More]
Scientists identify novel gene that affects brain function

Scientists identify novel gene that affects brain function

U.S. and Australian scientists have found the mechanism a novel gene uses to affect brain function and elicit behavior related to neuropsychiatric disease. [More]
NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

NYU Langone's Michael M. Halassa selected as winner of 2015 Sloan Research Fellowship

Michael M. Halassa, MD, PhD, assistant professor, Departments of Psychiatry and Neuroscience and Physiology at NYU Langone Medical Center's Neuroscience Institute, has been selected as a winner of the 2015 Sloan Research Fellowship. [More]
Rogers Behavioral Health announces addition of eating disorder program to Tampa location

Rogers Behavioral Health announces addition of eating disorder program to Tampa location

Rogers Behavioral Health-Tampa Bay announced today that it is adding a partial hospitalization eating disorder program to its Tampa location beginning March 30. This news is particularly timely as the nation recognizes National Eating Disorder Awareness Week February 22-28. [More]
Telephone-based peer support may help reduce postpartum depression in new mothers

Telephone-based peer support may help reduce postpartum depression in new mothers

New research reveals that telephone-based peer support may help reduce postnatal depression, also known as postpartum depression, in new mothers. Findings published in the Journal of Advanced Nursing also found that social support from peers may be effective for maternal depression up to two years after delivery. [More]
Diabetes, depression linked to higher risk of dementia in people with mild cognitive impairment

Diabetes, depression linked to higher risk of dementia in people with mild cognitive impairment

People with mild cognitive impairment are at higher risk of developing dementia if they have diabetes or psychiatric symptoms such as depression, finds a new review led by UCL researchers. [More]
Study: Growth hormone can improve social impairment in patients with Phelan-McDermid syndrome

Study: Growth hormone can improve social impairment in patients with Phelan-McDermid syndrome

A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome, according to a pilot study conducted at the Icahn School of Medicine at Mount Sinai and published yesterday on Pub Med, a public database of biomedical topics maintained by the National Institutes of Health (study originally published in the December 12 issue of the journal Molecular Autism). [More]